Tue, Nov 25, 2014, 7:53 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Galena Biopharma, Inc. Message Board

  • opinionscincy opinionscincy Mar 22, 2012 11:10 AM Flag

    Read " 5 Billion Now Annual Sales/1# Cancer Drug" link

    Breast cancer is one of the most common forms of cancer and is a disease with few options regarding treatment. Just look at Roche-Genetech's (RHHBY.PK); the company's drug Herceptin is one of the few advanced treatments for breast cancer patients, but only treats 25% of those diagnosed. NeuVax is believed to treat up to 75% (50% for sure) and with Herceptin returning $5 billion in annual sales, and only targeting 25% of patients, I think it is obvious why investors are so excited regarding the potential market for NeuVax.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
1.83-0.06(-3.17%)Nov 25 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.